Category survey

DRIVING PERFORMANCE IN PRECLINICAL ALZHEIMERS DISEASE

DRIVING PERFORMANCE IN PRECLINICAL ALZHEIMERS DISEASE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Archiving the Rancho Bernardo Study of Healthy Aging

Archiving the Rancho Bernardo Study of Healthy Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

YASHIN Admin Supp: Time Trends in Alzheimers Disease: Addressing the Changing Role of Risk Factors and Instrument Validity

YASHIN Admin Supp: Time Trends in Alzheimers Disease: Addressing the Changing Role of Risk Factors and Instrument Validity Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Analysis of Genome-Wide Data in the Health and Retirement Study

Analysis of Genome-Wide Data in the Health and Retirement Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Risk for Alzheimers Disease and Cognitive Decline in Project TALENT

Risk for Alzheimers Disease and Cognitive Decline in Project TALENT Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

School Quality and Racial Disparities in Alzheimers Disease in Project Talent

School Quality and Racial Disparities in Alzheimers Disease in Project Talent Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Psychosocial Protective Factors in Cognitive and Brain Aging

Psychosocial Protective Factors in Cognitive and Brain Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Self-Regulation, Immunological Aging, and Health in Older Adults

Self-Regulation, Immunological Aging, and Health in Older Adults Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Self-Regulation, Immunological Aging, and Health in Older Adults

Self-Regulation, Immunological Aging, and Health in Older Adults Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Community-based End-of-life Intervention for African American Dementia Caregivers

Community-based End-of-life Intervention for African American Dementia Caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Improving Outcomes for Family Caregivers and Older Adults with Complex Conditions: The Adult Day Service Plus Program

Improving Outcomes for Family Caregivers and Older Adults with Complex Conditions: The Adult Day Service Plus Program Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimers Caregivers

Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimers Caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Web-based Behavioral Activation for Alzheimers Caregivers

Web-based Behavioral Activation for Alzheimers Caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Hip Fracture Caregiver Intervention Function Focused Care Hip Care at Home

Hip Fracture Caregiver Intervention Function Focused Care Hip Care at Home Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Promoting Caregiver Resilience During Medical Crises of Persons Living with Dementia

Promoting Caregiver Resilience During Medical Crises of Persons Living with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Adapting and testing an Alzheimers family caregiver intervention in Vietnam

Adapting and testing an Alzheimers family caregiver intervention in Vietnam Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services

From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy

Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimers Disease

Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach

Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Long-Term Nicotine Treatment of Mild Cognitive Impairment

Long-Term Nicotine Treatment of Mild Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Alzheimers Disease Cooperative Study

Alzheimers Disease Cooperative Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Indiana University Dementia Screening Trial: The IU CHOICE Study

Indiana University Dementia Screening Trial: The IU CHOICE Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Self-Directed Online Training Intervention for Chinese Dementia Caregivers

Self-Directed Online Training Intervention for Chinese Dementia Caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Socially Assistive Robotic Architecture for Elder Care

Socially Assistive Robotic Architecture for Elder Care Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Caregivers Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS

Caregivers Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

EPIC: A Group-based Intervention for Early-stage AD Dyads in Diverse Communities

EPIC: A Group-based Intervention for Early-stage AD Dyads in Diverse Communities Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Burden, depression, and health in dementia caregivers: The role of emotion

Burden, depression, and health in dementia caregivers: The role of emotion Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Strategies for Managing Persons with Dementia in Assisted Living

Strategies for Managing Persons with Dementia in Assisted Living Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Transitions to Family Caregiving and Its Impact on Health Indicators

Transitions to Family Caregiving and Its Impact on Health Indicators Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Current and Future Costs of Alzheimers and Dementia Care

Current and Future Costs of Alzheimers and Dementia Care Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients

Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Tools for Coordination Among Caregivers of Patients with Alzheimers Disease and Other Dementias

Tools for Coordination Among Caregivers of Patients with Alzheimers Disease and Other Dementias Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Guardianship and Medical Decision Making for the Unbefriended Elderly

Guardianship and Medical Decision Making for the Unbefriended Elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

A non-pharmacological intervention for patients with Alzheimer s disease and family caregivers

A non-pharmacological intervention for patients with Alzheimer s disease and family caregivers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

HOME 4 CARE–the Hearthstone Optimized Multimedia Environment for Care-planning, Activities, Recreation, and Education

HOME 4 CARE–the Hearthstone Optimized Multimedia Environment for Care-planning, Activities, Recreation, and Education Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

The structural and functional connectome across Alzheimers disease subtypes

The structural and functional connectome across Alzheimers disease subtypes Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Comprehensive Longitudinal Probabilistic Atlas of the Brain of Older Adults Without Dementia

Comprehensive Longitudinal Probabilistic Atlas of the Brain of Older Adults Without Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimers disease pathologies andcognitive decline

Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimers disease pathologies andcognitive decline Investments > €500k United States of America Alzheimer’s disease & other dementias 2016